Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis

Clinical trial NCT01244958 · COMPLETED

Trial details

NCT number: NCT01244958
Sponsor: Frank Behrens
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2010-08-01
Primary completion: 2015-02-01
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.